News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,065 Results
Type
Article (40926)
Company Profile (293)
Press Release (652846)
Section
Business (206029)
Career Advice (2021)
Deals (35673)
Drug Delivery (85)
Drug Development (81173)
Employer Resources (168)
FDA (16218)
Job Trends (14996)
News (347911)
Policy (32894)
Tag
Academia (2612)
Alliances (49888)
Alzheimer's disease (1241)
Approvals (16151)
Artificial intelligence (131)
Bankruptcy (356)
Best Places to Work (11603)
Biotechnology (207)
Breast cancer (120)
Cancer (1093)
Cardiovascular disease (99)
Career advice (1689)
Cell therapy (234)
Clinical research (64435)
Collaboration (390)
Compensation (200)
COVID-19 (2580)
C-suite (96)
Data (1129)
Diabetes (152)
Diagnostics (6310)
Earnings (85263)
Employer resources (146)
Events (110266)
Executive appointments (311)
FDA (16757)
Funding (357)
Gene therapy (179)
GLP-1 (587)
Government (4373)
Healthcare (18804)
Infectious disease (2666)
Inflammatory bowel disease (106)
Interviews (312)
IPO (16367)
Job creations (3746)
Job search strategy (1444)
Layoffs (415)
Legal (7971)
Lung cancer (173)
Manufacturing (177)
Medical device (13239)
Medtech (13244)
Mergers & acquisitions (19380)
Metabolic disorders (403)
Neuroscience (1516)
NextGen Class of 2024 (6537)
Non-profit (4520)
Northern California (1483)
Obesity (232)
Opinion (182)
Patents (102)
People (56905)
Phase I (20029)
Phase II (28364)
Phase III (21152)
Pipeline (460)
Postmarket research (2574)
Preclinical (8611)
Radiopharmaceuticals (237)
Rare diseases (220)
Real estate (6100)
Regulatory (21824)
Research institute (2371)
Resumes & cover letters (350)
Southern California (1307)
Startups (3607)
United States (13552)
Vaccines (552)
Weight loss (168)
Date
Today (138)
Last 7 days (735)
Last 30 days (3749)
Last 365 days (35861)
2024 (32906)
2023 (40331)
2022 (51424)
2021 (56015)
2020 (54494)
2019 (46960)
2018 (35321)
2017 (32506)
2016 (31973)
2015 (37999)
2014 (31857)
2013 (26978)
2012 (29100)
2011 (29777)
2010 (27816)
Location
Africa (729)
Arizona (194)
Asia (37922)
Australia (6197)
California (3338)
Canada (1297)
China (249)
Colorado (148)
Connecticut (152)
Europe (81514)
Florida (460)
Georgia (117)
Illinois (343)
Indiana (197)
Kansas (96)
Maryland (581)
Massachusetts (2612)
Michigan (157)
Minnesota (278)
New Jersey (961)
New York (966)
North Carolina (717)
Northern California (1483)
Ohio (140)
Pennsylvania (846)
South America (1121)
Southern California (1307)
Texas (468)
Utah (92)
Washington State (364)
694,065 Results for "idexx laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - February 20, 2024
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming conferences.
February 20, 2024
·
1 min read
Genetown
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis.
June 4, 2024
·
5 min read
Genetown
IDEXX Laboratories Schedules Two Institutional Investor Events
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events.
December 7, 2023
·
1 min read
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
IDEXX Laboratories, Inc. announces the launch of the IDEXX inVue Dx™ Cellular Analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples.
January 12, 2024
·
6 min read
Business
IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens.
January 23, 2024
·
1 min read
Business
IDEXX Laboratories Announces 2023 Third Quarter Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced third quarter results.
November 1, 2023
·
33 min read
Business
IDEXX Announces Fourth Quarter and Full Year 2023 Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced fourth quarter and full year results.
February 5, 2024
·
35 min read
Business
IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, November 1, 2023 before the market opens.
October 5, 2023
·
1 min read
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
IDEXX Laboratories, Inc. announced the expansion of its Fecal Dx ® antigen testing platform with the addition of Cystoisospora.
January 12, 2024
·
6 min read
Business
IDEXX Laboratories Elects Irene Chang Britt to Board of Directors
IDEXX Laboratories, Inc. today announced the election of Irene Chang Britt, a former executive at Campbell Soup Company, to the Company’s Board of Directors, effective July 11, 2023.
July 12, 2023
·
3 min read
1 of 69,407
Next
